J Wojta Selected Research

human MIRN132 microRNA

1/2020

Roux-en-Y-Bariatric Surgery Reduces Markers of Metabolic Syndrome in Morbidly Obese Patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J Wojta Research Topics

Disease

8	Inflammation (Inflammations) 12/2016 - 04/2005
7	Atherosclerosis 11/2017 - 09/2001
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2013 - 09/2001
4	Atherosclerotic Plaque (Atheroma) 06/2014 - 08/2006
3	Heart Failure 10/2021 - 02/2010
3	Carotid Stenosis (Carotid Artery Stenosis) 01/2017 - 11/2006
3	Thrombosis (Thrombus) 12/2016 - 09/2001
3	Abdominal Aortic Aneurysm 05/2015 - 08/2012
3	Coronary Artery Disease (Coronary Atherosclerosis) 08/2010 - 07/2001
2	Insulin Resistance 01/2020 - 09/2001
2	Atrial Fibrillation 08/2016 - 06/2013
2	Necrosis 08/2012 - 08/2006
2	Rupture 03/2011 - 08/2006
2	Myocardial Infarction 12/2007 - 09/2001
1	Hyperinsulinism (Hyperinsulinemia) 01/2020
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020
1	Weight Loss (Weight Reduction) 01/2018
1	Premature Aging 01/2018
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2017
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 11/2017
1	Ischemia 11/2017
1	Pneumonia (Pneumonitis) 12/2016
1	Thromboembolism 08/2016
1	Vascular Diseases (Vascular Disease) 08/2016
1	Stroke (Strokes) 08/2016
1	Hypertension (High Blood Pressure) 08/2016
1	Hyperoxia 04/2016
1	Acute Kidney Injury (Acute Renal Failure) 01/2016
1	Carotid Artery Diseases 01/2016
1	Heart Diseases (Heart Disease) 05/2013
1	Overweight 05/2013
1	Morbid Obesity 05/2013
1	Obesity 05/2013
1	Coronary Disease (Coronary Heart Disease) 11/2012
1	Aneurysm (Aneurysms) 08/2012
1	Coronary Stenosis (Coronary Artery Stenosis) 05/2011

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 01/2018 - 05/2013
3	Plasminogen Activator Inhibitor 1IBA 01/2018 - 09/2001
3	NF-kappa B (NF-kB)IBA 04/2016 - 08/2012
3	Simvastatin (Zocor)FDA LinkGeneric 05/2015 - 08/2012
3	Complement System Proteins (Complement)IBA 01/2013 - 08/2006
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2012 - 01/2007
2	Biomarkers (Surrogate Marker)IBA 10/2021 - 03/2011
2	MicroRNAs (MicroRNA)IBA 01/2020 - 01/2018
2	Interleukin-6 (Interleukin 6)IBA 01/2018 - 04/2005
2	Lipocalin-2IBA 01/2017 - 01/2016
2	Messenger RNA (mRNA)IBA 01/2016 - 06/2014
2	LipopolysaccharidesIBA 01/2016 - 01/2001
2	Interleukin-33IBA 06/2014 - 05/2013
2	AntibodiesIBA 01/2013 - 08/2006
2	oxidized low density lipoproteinIBA 01/2013 - 11/2012
2	CytokinesIBA 02/2010 - 04/2005
2	Macrophage Colony-Stimulating FactorIBA 02/2010 - 12/2007
2	Plasminogen InactivatorsIBA 09/2001 - 07/2001
1	EnzymesIBA 01/2020
1	human MIRN130 microRNAIBA 01/2020
1	human MIRN132 microRNAIBA 01/2020
1	C-PeptideIBA 01/2020
1	Insulin (Novolin)FDA Link 01/2020
1	ProinsulinIBA 01/2020
1	AngiopoietinsIBA 11/2017
1	Phosphotransferases (Kinase)IBA 11/2017
1	Apolipoproteins E (ApoE)IBA 11/2017
1	Imatinib Mesylate (Gleevec)FDA Link 11/2017
1	nilotinib FDA Link 11/2017
1	Metformin (Glucophage)FDA LinkGeneric 01/2017
1	EndotoxinsIBA 12/2016
1	GlucocorticoidsIBA 12/2016
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 04/2016
1	Oxygen (Dioxygen)IBA 04/2016
1	Matrix Metalloproteinases (MMPs)IBA 05/2015
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 06/2014
1	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2013
1	Carrier Proteins (Binding Protein)IBA 06/2013
1	AntigensIBA 06/2013
1	Cyclophilin AIBA 06/2013
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 06/2013
1	P-SelectinIBA 06/2013
1	InterleukinsIBA 05/2013
1	CholesterolIBA 11/2012
1	HDL CholesterolIBA 11/2012
1	LDL CholesterolIBA 11/2012
1	Free RadicalsIBA 08/2012
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 08/2012
1	CatalaseIBA 08/2012
1	Superoxide DismutaseIBA 08/2012
1	Fas Ligand Protein (Fas Ligand)IBA 05/2011
1	AnaphylatoxinsIBA 03/2011
1	Complement C3-C5 Convertases (C3 Convertase)IBA 03/2011
1	LectinsIBA 03/2011
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 03/2011
1	Enoxaparin (Lovenox)FDA LinkGeneric 08/2010

Therapy/Procedure

3	Therapeutics 01/2013 - 08/2010
2	Gastric Bypass (Roux-en-Y Gastric Bypass) 01/2020 - 01/2018
2	Bariatric Surgery 01/2020 - 01/2018
2	Carotid Endarterectomy 01/2016 - 11/2006
2	Thrombolytic Therapy 08/2010 - 09/2001
1	Electric Countershock (Cardioversion) 08/2016
1	Endarterectomy (Thromboendarterectomy) 01/2016
1	Percutaneous Coronary Intervention 05/2011